Allarity Therapeutics, Inc. - Common stock (ALLR)

Allarity Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative cancer therapies that target specific molecular drivers of tumors

The company utilizes its proprietary drug development platform to identify and enhance the effectiveness of treatments tailored for individual patient profiles, particularly in cases of advanced or difficult-to-treat cancers. By leveraging advanced technologies, Allarity aims to improve patient outcomes through personalized medicine approaches that align therapies with the unique characteristics of a patient's tumor, ultimately striving to bring more effective options to the oncology landscape.